UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003071
Receipt number R000003726
Scientific Title Financial support for off-label prescription in patients with severe adverse drug reaction due to cancer chemotherapy
Date of disclosure of the study information 2010/01/31
Last modified on 2017/07/30 07:11:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Financial support for off-label prescription in patients with severe adverse drug reaction due to cancer chemotherapy

Acronym

How to support financially for off-label prescription

Scientific Title

Financial support for off-label prescription in patients with severe adverse drug reaction due to cancer chemotherapy

Scientific Title:Acronym

How to support financially for off-label prescription

Region

Japan


Condition

Condition

Breast cancer

Classification by specialty

Medicine in general Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To reimburse medical cost of off-label prescription severe adverse chemotherapy drug reaction when patients did not use public medical insurance

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Adverse drug reactions

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Medical cost payment

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Breast cancer patients
Reducing chemotherapy dose may affect clinical efficacy
Informed consent

Key exclusion criteria

Contraindication for medication

Target sample size

150


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroshi Ishiguro

Organization

Graduate School of Medicine Kyoto University

Division name

Department of Target Therapy Oncology

Zip code


Address

54 Syogoinkawahara-machi, Sakyo-ku, Kyoto-city

TEL

075-751-4950

Email

hkkishi@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tomoko Okuda

Organization

kyoto University Hospital

Division name

Department of Breast Surgery

Zip code


Address

54 Syogoinkawahara-machi, Sakyo-ku, Kyoto-city

TEL

075-751-3660

Homepage URL


Email

oku@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University Hospital

Institute

Department

Personal name



Funding Source

Organization

Medical Research Fund

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 01 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 01 Month 21 Day

Date of IRB


Anticipated trial start date

2010 Year 02 Month 01 Day

Last follow-up date

2017 Year 06 Month 30 Day

Date of closure to data entry

2017 Year 06 Month 30 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 01 Month 21 Day

Last modified on

2017 Year 07 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003726


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name